Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Lode

Showing results (261-270 of 369) with videos related to

Pageof 37
Sort By:
Antimicrobial Agents and Chemotherapy|May 1, 1995
Interaction study of lomefloxacin and ciprofloxacin with omeprazole and comparative pharmacokineticsH Stuht, H Lode, P Koeppe, et al.
Der Internist|December 29, 2000
[Nosocomial pneumonia. Epidemiology, pathogenesis and diagnosis]H Lode, R Erbes, H Geerdes-Fenge, et al.
Infection|January 31, 2008
Moxifloxacin vs ampicillin/sulbactam in aspiration pneumonia and primary lung abscessS R Ott, M Allewelt, J Lorenz, et al.
Der Anaesthesist|February 28, 2001
[Nosocomial pneumonia. Epidemiology, pathogenesis and diagnosis]H Lode, R Erbes, H Geerdes-Fenge, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 5, 2004
Ampicillin + sulbactam vs clindamycin +/- cephalosporin for the treatment of aspiration pneumonia and primary lung abscessM Allewelt, P Schüler, P L Bölcskei, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1993
Comparative pharmacokinetics and serum bactericidal activities of SCE-2787 and ceftazidimeW Paulfeuerborn, H J Müller, K Borner, et al.
Pneumologie (Stuttgart, Germany)|October 1, 1996
[MRSA (methicillin-resistant Staphylococcus aureus) infections in patients with pulmonary diseases]R Erbes, A Wagner, T Schaberg, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 1990
Quinolone pharmacokinetics and metabolismH Lode, G Höffken, M Boeckk, et al.
Medizinische Klinik (Munich, Germany : 1983)|July 15, 1989
[Infection 1979 to 1986. Epidemiology, etiology, clinical aspects and prognosis in 691 patients]F Müller, M Hund, J Löhr, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 20, 2003
Serum bactericidal activity of trovafloxacin, in combination with cefepime or amikacin, in healthy volunteersA Lubasch, S Ziege, B Brodersen, et al.
Pageof 37

Showing results (261-270 of 369) with videos related to

Sort By:
Pageof 37
Antimicrobial Agents and Chemotherapy|May 1, 1995
Interaction study of lomefloxacin and ciprofloxacin with omeprazole and comparative pharmacokineticsH Stuht, H Lode, P Koeppe, et al.
Der Internist|December 29, 2000
[Nosocomial pneumonia. Epidemiology, pathogenesis and diagnosis]H Lode, R Erbes, H Geerdes-Fenge, et al.
Infection|January 31, 2008
Moxifloxacin vs ampicillin/sulbactam in aspiration pneumonia and primary lung abscessS R Ott, M Allewelt, J Lorenz, et al.
Der Anaesthesist|February 28, 2001
[Nosocomial pneumonia. Epidemiology, pathogenesis and diagnosis]H Lode, R Erbes, H Geerdes-Fenge, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 5, 2004
Ampicillin + sulbactam vs clindamycin +/- cephalosporin for the treatment of aspiration pneumonia and primary lung abscessM Allewelt, P Schüler, P L Bölcskei, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1993
Comparative pharmacokinetics and serum bactericidal activities of SCE-2787 and ceftazidimeW Paulfeuerborn, H J Müller, K Borner, et al.
Pneumologie (Stuttgart, Germany)|October 1, 1996
[MRSA (methicillin-resistant Staphylococcus aureus) infections in patients with pulmonary diseases]R Erbes, A Wagner, T Schaberg, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 1990
Quinolone pharmacokinetics and metabolismH Lode, G Höffken, M Boeckk, et al.
Medizinische Klinik (Munich, Germany : 1983)|July 15, 1989
[Infection 1979 to 1986. Epidemiology, etiology, clinical aspects and prognosis in 691 patients]F Müller, M Hund, J Löhr, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 20, 2003
Serum bactericidal activity of trovafloxacin, in combination with cefepime or amikacin, in healthy volunteersA Lubasch, S Ziege, B Brodersen, et al.
Pageof 37